Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Dec;24(4):132-133.

2017 Update of the Drug Resistance Mutations in HIV-1

Annemarie M Wensing  1 , Vincent Calvez  2 , Huldrych F Günthard  3 , Victoria A Johnson  4 , Roger Paredes  5 , Deenan Pillay  6 , Robert W Shafer  7 , Douglas D Richman  8
Affiliations

2017 Update of the Drug Resistance Mutations in HIV-1

Annemarie M Wensing et al. Top Antivir Med. 2016 Dec.

Abstract

The 2017 edition of the IAS-USA drug resistance mutations list updates the figures last published in November 2015. The mutations listed are those that have been identified by specific criteria for evidence and drugs described. The figures are designed to assist practitioners in identifying key mutations associated with resistance to antiretroviral drugs and, therefore, in making clinical decisions regarding antiretroviral therapy.

PubMed Disclaimer

References

    1. Wensing AM, Calvez V, Günthard HF, et al. 2015 Update of the drug resistance mutations in HIV-1. Top Antivir Med. 2015; 23(4): 132–141. - PMC - PubMed
    1. Hirsch MS, Günthard HF, Schapiro JM, et al. Antiretroviral drug resistance testing in adult HIV-1 infection: 2008 recommendations of an International AIDS Society–USA panel. Clin Infect Dis. 2008; 47(2): 266–285. - PubMed
    1. Günthard HF, Saag MS, Benson CA, et al. Antiretroviral drugs for treatment and prevention of HIV infection in adults: 2016 recommendations of the International Antiviral Society–USA panel. JAMA. 2016; 316(2): 191–210. - PMC - PubMed

LinkOut - more resources